Bristol-Myers Squibb Company (NYSE: BMY) reported third-quarter 2020 financial results before the market opened on Thursday. The pharmaceutical company reported a 75%
Bristol-Myers Squibb beats in Q3, raises guidance
Categories
Health Care
Lannett Inc. (LCI) Q1 2021 Earnings Call Transcript
Lannett Inc. (NYSE: LCI) Q1 2021 earnings call dated Nov. 04, 2020 Corporate Participants: Robert Jaffe -- President, Robert Jaffe Co., LLC Timothy C.
Humana Inc (HUM) Q3 2020 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q3 2020 earnings call dated Nov. 03, 2020 Corporate Participants: Amy K. Smith -- Vice President, Investor Relations Bruce D.
Bausch Health Companies Inc. (BHC) Q3 2020 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE: BHC) Q3 2020 earnings call dated Nov. 03, 2020 Corporate Participants: Arthur Shannon -- Senior Vice President of Investor
McKesson Corp. (MCK) Q2 2021 Earnings Call Transcript
McKesson Corp. (NYSE: MCK) Q2 2021 earnings call dated Nov. 03, 2020 Corporate Participants: Holly Weiss -- Senior Vice President, Investor Relations Brian S.
AbbVie (ABBV) to focus more on pipeline as recovery gathers pace
AbbVie, Inc. (NYSE: ABBV) has been recovering steadily from the virus-related slowdown and latest statistics show that the company's performance has improved
Eagle Pharmaceuticals Inc. (EGRX) Q3 2020 Earnings Call Transcript
Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) Q3 2020 Earnings Call dated Nov. 02, 2020 Corporate Participants: Lisa M. Wilson -- Investor Relations - In-Site Communications,
AbbVie Inc. (ABBV) Q3 2020 Earnings Call Transcript
AbbVie Inc. (NYSE: ABBV) Q3 2020 earnings call dated Oct. 30, 2020 Corporate Participants: Liz Shea -- Investor Relations Richard A. Gonzalez -- Chairman of the
AbbVie shares gain after Q3 results beat estimates: Infographic
AbbVie (NYSE: ABBV) reported third-quarter 2020 financial results before the regular trading hours on Friday. The pharmaceutical behemoth reported Q3 revenue of
Illumina Inc. (ILMN) Q3 2020 Earnings Call Transcript
Illumina Inc. (NASDAQ: ILMN) Q3 2020 earnings call dated Oct. 29, 2020 Corporate Participants: Juliet Cunningham -- Vice President, Investor Relations Francis deSouza -- President and
SingleCare deal aimed at growing subscribers: Trxade CEO Suren Ajjarapu
Trxade (NASDAQ: MEDS) may have been on a dream run of late due to the strong demand for PPE, but the drug
Moderna Inc. (MRNA) Q3 2020 Earnings Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q3 2020 earnings call dated Oct. 29, 2020 Corporate Participants: Lavina Talukdar -- Senior Vice President & Head of Investor
Moderna reports higher earnings, wider loss in Q3
Moderna Inc (NASDAQ: MRNA) reported third-quarter 2020 financial results before the opening bell on Thursday. The frontrunner in COVID vaccine research reported
Amgen Inc. (AMGN) Q3 2020 Earnings Call Transcript
Amgen Inc. (NASDAQ: AMGN) Q3 2020 earnings call dated Oct. 28, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations Robert A. Bradway -- Chairman
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the
Centene Corp. (CNC) Q3 2020 Earnings Call Transcript
Centene Corp. (NYSE: CNC) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance & Investor Relations
Eli Lilly and Company (LLY) Q3 2020 Earnings Call Transcript
Eli Lilly and Company (NYSE : LLY) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Kevin Hern -- Vice President, Investor Relations
Pfizer Inc (PFE) Q3 2020 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q3 2020 Earnings Call dated Oct. 27, 2020. Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert Bourla -- Chairman
Laboratory Corp Of America Holdings (LH) Q3 2020 Earnings Call Transcript
Laboratory Corp Of America Holdings (NYSE: LH) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Clarissa Willett -- Vice President, Investor Relations
Merck & Co. Inc. (MRK) Q3 2020 Earnings Call Transcript
Merck & Co. Inc. (NYSE: MRK) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Kenneth
Pfizer (PFE) posts mixed results in Q3
Pfizer Inc (NYSE: PFE) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 4% decline